Bard Financial Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.08M | Sell |
27,825
-1,020
| -4% | -$113K | 0.37% | 68 |
|
|
2025
Q1 | $3.23M | Sell |
28,845
-1,250
| -4% | -$140K | 0.4% | 63 |
|
|
2024
Q4 | $2.78M | Hold |
30,095
| – | – | 0.33% | 68 |
|
|
2024
Q3 | $2.52M | Sell |
30,095
-2,675
| -8% | -$224K | 0.3% | 74 |
|
|
2024
Q2 | $2.25M | Sell |
32,770
-375
| -1% | -$25.7K | 0.23% | 84 |
|
|
2024
Q1 | $2.43M | Buy |
33,145
+250
| +0.8% | +$18.3K | 0.26% | 81 |
|
|
2023
Q4 | $2.66M | Sell |
32,895
-2,375
| -7% | -$192K | 0.3% | 74 |
|
|
2023
Q3 | $2.64M | Buy |
35,270
+275
| +0.8% | +$20.6K | 0.33% | 67 |
|
|
2023
Q2 | $2.7M | Sell |
34,995
-150
| -0.4% | -$11.6K | 0.2% | 99 |
|
|
2023
Q1 | $2.92M | Sell |
35,145
-750
| -2% | -$62.2K | 0.23% | 89 |
|
|
2022
Q4 | $3.08M | Sell |
35,895
-500
| -1% | -$42.9K | 0.26% | 90 |
|
|
2022
Q3 | $2.25M | Buy |
36,395
+975
| +3% | +$60.1K | 0.21% | 102 |
|
|
2022
Q2 | $2.19M | Sell |
35,420
-1,200
| -3% | -$74.2K | 0.2% | 104 |
|
|
2022
Q1 | $2.18M | Buy |
36,620
+775
| +2% | +$46.1K | 0.18% | 108 |
|
|
2021
Q4 | $2.6M | Buy |
35,845
+175
| +0.5% | +$12.7K | 0.21% | 100 |
|
|
2021
Q3 | $2.49M | Buy |
35,670
+125
| +0.4% | +$8.73K | 0.22% | 101 |
|
|
2021
Q2 | $2.45M | Buy |
35,545
+1,000
| +3% | +$68.9K | 0.22% | 100 |
|
|
2021
Q1 | $2.23M | Hold |
34,545
| – | – | 0.22% | 101 |
|
|
2020
Q4 | $2.01M | Buy |
+34,545
| New | +$2.01M | 0.2% | 102 |
|